Pharmacoeconomic analisis of the use of drugs for the treatment of stomach and duodenum peptic ulcers

  • T.A. Germanyuk -
  • N.A. Volotska -
  • S.P. Dzyubenko -
Keywords: Helicobacter pylori, eradication, peptic ulcer disease, the method of the cost- minimization, proton pump inhibitors, pharmacoeconomic analysis

Abstract

The most cost-effective medicines to treat stomach and duodenum ulcers have been determined by the cost-minimization analysis subject to the same efficiency. It was found that the most economically sound is the appointment of treatment regimen, which includes Lanpro (Unichem Laboratories) capsules. 30 mg № 20, Clarithromycin Norton (Norton) Tabl. 500 mg № 7, Metronidazol (Lubnifarm) Tabl. 250 mg № 10, the cost of a 7-day course, which is 61.39 UAN.

References

1. Anti-Helicobacter Therapy: What's New in the III Maastricht Agreement? / Prepared by D.Molchanov // Medical newspaper "Health of Ukraine". - 2006. - № 9/1. - pp. 19-20.

2. Gerasimova OO, Zagrebelna Yu.M. Pharmacoeconomic analysis of various regimens of anti-helicobacter therapy for gastric and duodenal ulcer // "Rational pharmacotherapy". - 2010. - № 4. - P. 32-36.

3. Mayev IV, Samsonov NN, Golubev NN Clarithromycin as an integral component of anthelicobacter therapy // PHARMATEKA. - 2009. - № 6. - P. 22-29.

4. Samsonov AA, Golubev NN Prospects and problems of anthelicobacter therapy // Medicinski Vestnik. - 2009. - № 9 (478). - pp. 18-35.

5. Stepanov Yu.M., Vlasova OM Modern possibilities of optimization of anthelicobacter bacterial therapy // Journal of Internal Medicine. - 2009. -№ 4 (16). - P. 18-23.
Published
2019-07-01
How to Cite
Germanyuk, T., Volotska, N., & Dzyubenko, S. (2019). Pharmacoeconomic analisis of the use of drugs for the treatment of stomach and duodenum peptic ulcers. Farmatsevtychnyi Zhurnal, (4), 10-17. Retrieved from https://pharmj.org.ua/index.php/journal/article/view/625
Section
Pharmacoeconomics